vitamin-k-semiquinone-radical and Depressive-Disorder

vitamin-k-semiquinone-radical has been researched along with Depressive-Disorder* in 2 studies

Other Studies

2 other study(ies) available for vitamin-k-semiquinone-radical and Depressive-Disorder

ArticleYear
Symptoms of depression and anxiety predict mortality in patients undergoing oral anticoagulation: Results from the thrombEVAL study program.
    International journal of cardiology, 2015, Volume: 187

    Depression and anxiety are highly prevalent in cardiovascular patients. Therefore, we examined whether the 4-item Patient Health Questionnaire (PHQ-4, measuring symptoms of depression and anxiety) predicts all-cause mortality in outpatients with long-term oral anticoagulation (OAC).. The sample comprised n=1384 outpatients from a regular medical care setting receiving long-term OAC with vitamin K antagonists. At baseline, symptoms of anxiety and depression were assessed with the PHQ-4 and the past medical history was taken. The outcome was all-cause mortality in the 24 month observation period. The median follow-up time was 13.3 months.. N=191 patients from n=1384 died (death rate 13.8%). Each point increase in the PHQ-4 score was associated with a 10% increase in mortality (hazard ratio [HR] 1.10, 95% confidence interval [95% CI] 1.05-1.16) after adjustment for age, sex, high school graduation, partnership, smoking, obesity, frailty according to the Barthel Index, Charlson Comorbidity Index and CHA2DS2-VASc score. The depression component (PHQ-2) increased mortality by 22% and anxiety (GAD-2) by 11% respectively. Neither medical history of any mental disorder, nor intake of antidepressants, anxiolytics or hypnotics predicted excess mortality.. Elevated symptoms of depression and, to a lesser degree, symptoms of anxiety are independently associated with all-cause mortality in OAC outpatients. The PHQ-4 questionnaire provides valuable prognostic information. These findings emphasize the need for implementing regular screening procedures and the development and evaluation of appropriate psychosocial treatment approaches for OAC patients.

    Topics: Aged; Aged, 80 and over; Anticoagulants; Anxiety Disorders; Cardiovascular Diseases; Depressive Disorder; Female; Humans; Male; Mass Screening; Middle Aged; Prospective Studies; Sickness Impact Profile; Surveys and Questionnaires; Vitamin K

2015
Superwarfarin toxicity.
    American journal of therapeutics, 1998, Volume: 5, Issue:2

    Topics: 4-Hydroxycoumarins; Blood Transfusion; Depressive Disorder; Drug Monitoring; Emergency Treatment; Female; Humans; Middle Aged; Poisoning; Prothrombin Time; Rodenticides; Suicide, Attempted; Vitamin K

1998